Cardiac troponin T before and after kidney transplantation: Determinants and implications for posttransplant survival

American Journal of Transplantation

Volumn 13, Issue 2, 2013, Pages 406-414

  Keddis, M T ^a   El Zoghby, Z M ^a   El Ters, M ^a   Rodrigo, E ^a   Pellikka, P A ^a   Jaffe, A S ^a   Cosio, F G ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cardiac troponin; cardiovascular morbidity; kidney transplantation; survival

Indexed keywords

TROPONIN T;

ADULT; AGE DISTRIBUTION; ALLOGRAFT; ARTICLE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIALYSIS; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART DEATH; HEART DISEASE; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR;

ADULT; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TROPONIN T;

EID: 84873094523     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04317.x     Document Type: Article

References (42)

1. Herzog CA,. How to manage the renal patient with coronary heart disease: The agony and the ecstasy of opinion-based medicine. J Am Soc Nephrol 2003; 14: 2556-2572.
2. Muntner P, He J, Hamm L, Loria C, Whelton PK,. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 2002; 13: 745-753.
3. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE,. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 1995; 5: 2024-2031.
4. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS,. Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors. Kidney Int 1995; 47: 884-890.
5. Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47: 186-192.
6. Jaffe AS, Babuin L, Apple FS,. Biomarkers in acute cardiac disease: The present and the future. J Am Coll Cardiol 2006; 48: 1-11.
7. Deegan PB, Lafferty ME, Blumsohn A, Henderson IS, McGregor E,. Prognostic value of troponin T in hemodialysis patients is independent of comorbidity. Kidney Int 2001; 60: 2399-2405.
8. Apple FS, Murakami MM, Pearce LA, Herzog CA,. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002; 106: 2941-2945.
9. Hickson LJ, Cosio FG, El-Zoghby ZM, et al. Survival of patients on the kidney transplant wait list: Relationship to cardiac troponin T. Am J Transplant 2008; 8: 2352-2359.
10. Sharma R, Pellerin D, Gaze DC, et al. Dobutamine stress echocardiography and cardiac troponin T for the detection of significant coronary artery disease and predicting outcome in renal transplant candidates. Eur J Echocardiogr 2005; 6: 327-335.
11. Hickson LT, El-Zoghby ZM, Lorenz EC, Stegall MD, Jaffe AS, Cosio FG,. Patient survival after kidney transplantation: Relationship to pretransplant cardiac troponin T levels. Am J Transplant 2009; 9: 1354-1361.
12. Sharma R, Pellerin D, Gaze DC, et al. Dobutamine stress echocardiography and cardiac troponin T for the detection of significant coronary artery disease and predicting outcome in renal transplant candidates. Eur J Echocardiogr 2005; 6: 327-335.
13. Wu AH, Jaffe AS, Apple FS, et al. National academy of clinical biochemistry laboratory medicine practice guidelines: Use of cardiac troponin and b-type natriuretic peptide or n-terminal prob-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. Clin Chem 2007; 53: 2086-2096.
14. Gabir MM, Hanson RL, Dabelea D, et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 2000; 23: 1108-1112.
15. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D,. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
16. Wu AH, Feng YJ, Roper L, Herbert K, Schweizer R,. Cardiac troponins T and I before and after renal transplantation. Clin Chem 1997; 43: 411-412.
17. Fredericks S, Chang R, Gregson H, et al. Circulating cardiac troponin-T in patients before and after renal transplantation. Clin Chim Acta 2001; 310: 199-203.
18. Ellis K, Dreisbach AW, Lertora JL,. Plasma elimination of cardiac troponin I in end-stage renal disease. South Med J 2001; 94: 993-996.
19. Abbas NA, John RI, Webb MC, et al. Cardiac troponins and renal function in nondialysis patients with chronic kidney disease. Clin Chem 2005; 51: 2059-2066.
20. Wallace TW, Abdullah SM, Drazner MH, et al Prevalence and determinants of troponin T elevation in the general population. Circulation 2006; 113: 1958-1965.
21. deFilippi CR, Thorn EM, Aggarwal M, et al. Frequency and cause of cardiac troponin T elevation in chronic hemodialysis patients from study of cardiovascular magnetic resonance. Am J Cardiol 2007; 100: 885-889.
22. Khan IA, Wattanasuwan N, Mehta NJ, et al. Prognostic value of serum cardiac troponin I in ambulatory patients with chronic renal failure undergoing long-term hemodialysis: A two-year outcome analysis. J Am Coll Cardiol 2001; 38: 991-998.
23. Joles JA, Vos IH, Grone HJ, Rabelink TJ,. Inducible nitric oxide synthase in renal transplantation. Kidney Int 2002; 61: 872-875.
24. Harter HR, Davis TA, Karl IE,. Enhanced muscle protein catabolism in uremia. Adv Exp Med Biol 1984; 167: 557-569.
25. Harter HR, Karl IE, Klahr S, Kipnis DM,. Effects of reduced renal mass and dietary protein intake on amino acid release and glucose uptake by rat muscle in vitro. J Clin Invest 1979; 64: 513-523.
26. Parfrey PS, Harnett JD, Foley RN, et al. Impact of renal transplantation on uremic cardiomyopathy. Transplantation 1995; 60: 908-914.
27. Cosio FG, Alamir A, Yim S, et al. Patient survival after renal transplantation: I. The impact of dialysis pre-transplant. Kidney Int 1998; 53: 767-772.
28. Meier-Kriesche HU, Kaplan B,. Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: A paired donor kidney analysis. Transplantation 2002; 74: 1377-1381.
29. Becker BN, Rush SH, Dykstra DM, Becker YT, Port FK,. Preemptive transplantation for patients with diabetes-related kidney disease. Arch Intern Med 2006; 166: 44-48.
30. Innocenti GR, Wadei HM, Prieto M, et al. Preemptive living donor kidney transplantation: Do the benefits extend to all recipients ? Transplantation 2007; 83: 144-149.
31. Kasiske BL, Snyder JJ, Matas AJ, Ellison MD, Gill JS, Kausz AT,. Preemptive kidney transplantation: The advantage and the advantaged. J Am Soc Nephrol 2002; 13: 1358-1364.
32. Ojo AO, Hanson JA, Wolfe RA, Leichtman AB, Agodoa LY, Port FK,. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000; 57: 307-313.
33. Meier-Kriesche HU, Baliga R, Kaplan B,. Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 2003; 75: 1291-1295.
34. Cosio FG, Hickson LJ, Griffin MD, Stegall MD, Kudva Y,. Patient survival and cardiovascular risk after kidney transplantation: The challenge of diabetes. Am J Transplant 2008; 8: 593-599.
35. Weiner DE, Carpenter MA, Levey AS, et al. Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: The FAVORIT Trial. Am J Transplant 2012; 12: 2437-2445.
36. Kasiske BL, Israni AK, Snyder JJ, Skeans MA,. The relationship between kidney function and long-term graft survival after kidney transplant. Am J Kidney Dis 2011; 57: 466-475.
37. Kaplan B, Schold J, Meier-Kriesche HU,. Poor predictive value of serum creatinine for renal allograft loss. Am J Transplant 2003; 3: 1560-1565.
38. Kasiske BL, Snyder SH, Gilbertson D, Matas AJ,. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2002; 3: 178-185.
39. Cosio FG, Kudva Y, van der Velde M, et al. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int 2005; 67: 2415-2421.
40. Gaston RS, Kasiske BL, Fieberg AM, et al. Use of cardioprotective medications in kidney transplant recipients. Am J Transplant 2009; 9: 1811-1815.
41. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-1730.
42. El-Zoghby ZM, Stegall MD, et al. Identifying specific causes of kidney allograft loss. Am J Transplant 2009; 9: 527-535.